Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2799 W Grand Blvd
Detroit, MI 48202Phone+1 313-916-2600Fax+1 313-916-3235
Education & Training
Wayne State University School of MedicineClass of 1979
Certifications & Licensure
MI State Medical License 1980 - 2026
FL State Medical License 1984 - 1989
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein Start of enrollment: 2023 Mar 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- 5 citationsIncidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018.Philip R Spradling, Jian Xing, Yuna Zhong, Loralee B Rupp, Anne C Moorman
The Journal of Infectious Diseases. 2022-09-13 - 18 citationsReview article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data.Young-Suk Lim, Wai-Kay Seto, Masayuki Kurosaki, Scott Fung, Jia-Horng Kao
Alimentary Pharmacology & Therapeutics. 2022-04-01 - 10 citationsRisk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.W Ray Kim, Laura E Telep, Belinda Jump, Mei Lu, Heribert Ramroth
Alimentary Pharmacology & Therapeutics. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
